Injectable, Extended-Release Buprenorphine Feasible for Opioid Use Disorder During Pregnancy

Summary: A recent study shows that a long-lasting shot of buprenorphine is safe and works very well for pregnant women dealing with opioid use disorder (OUD). Researchers compared this extended-release injection to the standard daily pill that dissolves under the tongue.

Women who got the injection stayed away from illegal opioids more often during their pregnancy (82.5% compared to 72.6% for the pill group). They also had fewer serious health problems during pregnancy and after giving birth. Both groups had similar success rates after the baby was born, and the babies in both groups had the exact same health needs regarding opioid treatment. Doctors say this long-acting medicine is an exciting new way to help pregnant women safely recover.

For more details, see rssapp-psychiatryadvisor-com at psychiatryadvisor.com/news/injectable-extended-release-buprenorphine-feasible-for-opioid-use-disorder-during-pregnancy/ (opens in new tab)